Vext Science, Inc.
VEXTF
$0.0936
$0.00040.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.56M | 10.19M | 8.99M | 8.43M | 8.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.56M | 10.19M | 8.99M | 8.43M | 8.39M |
| Cost of Revenue | 9.28M | 8.06M | 5.02M | 6.87M | 7.06M |
| Gross Profit | 2.28M | 2.14M | 3.97M | 1.55M | 1.33M |
| SG&A Expenses | 2.26M | 2.84M | 3.01M | 3.01M | 2.57M |
| Depreciation & Amortization | 2.16M | 2.19M | 2.25M | 2.30M | 2.00M |
| Other Operating Expenses | -45.90K | 374.00K | -- | -- | -- |
| Total Operating Expenses | 13.66M | 13.46M | 10.28M | 12.19M | 11.63M |
| Operating Income | -2.10M | -3.27M | -1.29M | -3.76M | -3.24M |
| Income Before Tax | -3.56M | -7.20M | -2.74M | -4.52M | -6.67M |
| Income Tax Expenses | -223.20K | 2.02M | -238.80K | -127.20K | -340.50K |
| Earnings from Continuing Operations | -3.33M | -9.22M | -2.50M | -4.39M | -6.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.33M | -9.22M | -2.50M | -4.39M | -6.33M |
| EBIT | -2.10M | -3.27M | -1.29M | -3.76M | -3.24M |
| EBITDA | 1.43M | 345.50K | 2.35M | -50.90K | 350.50K |
| EPS Basic | -0.01 | -0.04 | -0.01 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.04 | -0.01 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 247.49M | 247.44M | 245.55M | 245.45M | 225.13M |
| Average Diluted Shares Outstanding | 247.49M | 247.44M | 248.66M | 245.45M | 225.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |